Related Experiment Video

Updated: Aug 19, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Risk factors for the acquisition of hepatitis C

A Bergk1, T Berg, U P Neumann

  • 1Department of Medicine, Charité Medical Center, Virchow-Hospital, Medical School of the Humboldt-University, Berlin, Germany. alexandra.bergk@charite.de

Minerva Gastroenterologica E Dietologica
|March 10, 2005
PubMed

Insights

Hepatitis C virus (HCV) infection affects 170 million globally. Understanding transmission is key to preventing new infections and improving treatment strategies for chronic liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Chronic hepatitis C virus (HCV) infection impacts approximately 170 million individuals globally.
  • Current antiviral therapies achieve sustained virological response in a limited patient subset due to factors like non-response, relapse, contraindications, and cost.
  • Chronic HCV is a primary driver of end-stage liver disease, hepatocellular carcinoma, and liver transplantation in developed nations.

Purpose of the Study:

  • To review recent advancements in understanding HCV transmission pathways.
  • To outline future strategies for the prevention of hepatitis C infections.

Main Methods:

  • Literature review of recent studies on hepatitis C transmission.
  • Analysis of current prevention strategies and their effectiveness.
  • Synthesis of data to identify key risk factors and transmission routes.

Main Results:

  • Hepatitis C remains a significant global health challenge with limited treatment success.
  • Identifying transmission pathways is critical for effective public health interventions.
  • Advances in understanding transmission inform the development of targeted prevention strategies.

Conclusions:

  • Effective prevention of new hepatitis C infections requires comprehensive knowledge of transmission dynamics.
  • Future strategies should focus on risk factor mitigation and targeted public health initiatives.
  • Continued research into HCV transmission is essential for global health security.

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...